Funded Projects & People

Our program funding is allocated through a competitive process underpinned by robust expert review. We adopt scientific rigour to evaluate each proposal’s potential for impact and alignment with identified childhood cancer research and care priorities.

Funded projects

Projects supported by Children's Cancer CoLab

Filter by Impact Program
Clear
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Future Leaders
Next-Generation Therapies

Next Generation Paediatric Cancer Therapies Program

Combining multi-omic profiling and AI analytical tools to develop novel treatments for aggressive childhood cancers

Funded researchers and clinicians

Researchers and clinicians supported by Children's Cancer CoLab

Filter by Impact Program
Clear
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Next-Generation Therapies
Dr Iman Azimi
PhD
Senior Lecturer and Head, Cancer Drug Discovery and Cellular Ageing Lab

Dr Azimi's research focuses on drug discovery for medulloblastoma

Next-Generation Therapies
Prof Ron Firestein
MD PhD
Head of the Centre for Cancer Research

Prof Ron Firestein is the Head of the Centre for Cancer Research at Hudson Institute of Medical Research.

Future Leaders
Next-Generation Therapies
Dr Yichen Zhou
PhD
Postdoctoral researcher

Dr Yichen Zhou is a research scientist in the Next Generation Precision Medicine program

Future Leaders
Next-Generation Therapies
Dr Hanbyeol Lee
BSc PhD
Researcher

Dr Hanbyeol Lee is a research scientist with the Next Generation Precision Medicine team

Support us

More ways you can make an impact

Your support drives critical research and innovation that will change lives. By supporting Children's Cancer CoLab, you become part of a community working to ensure every young patient with cancer survives and thrives. Our approach unites top researchers across disciplines and institutions, breaking traditional barriers to accelerate discoveries from the lab to clinic, creating real impact for young cancer patients and their families.